Cetuximab and Encorafenib
About
Membership operator: AND
Therapies: 2
Therapies
Cetuximab (tx:ncit:C1723)
Encorafenib (tx:ncit:C98283)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (4) | BRAF p.V600E | Colorectal Adenocarcinoma | Cetuximab, Encorafenib |